2nd Quarter - Report

EISAI INC. for EISAI INC.

Firm
Client
Income
—
Expenses
$360,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Regulatory and legislative health care issues: 340B program; Value-based drug contracting; Proposals related to drug pricing; Issues related to global pharmaceutical supply chain; Bayh-Dole march-in rights; Medicare Part D Negotiation/Non-interference repeal bills; PDUFA reauthorization.

LobbyistCovered position, as disclosed
CHRISTOPHER BADGLEY —
TRICIA BROOKS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Policies to enhance patient access to medicines in Medicaid including rebate, waiver policy and funding issues; Access to medicines in Medicare; CMS NCD for Alzheimers therapies; Rebates and Medicare Part D - provisions related to the HHS-OIG Rebate Safe Harbor; Co-pay accumulators; Medicare Part D redesign proposals; Notice of Benefit and Payment Parameters; and Proposed Medicaid regulations.

LobbyistCovered position, as disclosed
CHRISTOPHER BADGLEY —
TRICIA BROOKS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Trade (domestic/foreign) TRD

Issues related to pharmaceutical IP and supply chain; World Trade Organization waiver of Trade-Related Aspects of Intellectual Property Rights (TRIPS).

LobbyistCovered position, as disclosed
CHRISTOPHER BADGLEY —
TRICIA BROOKS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.